Ari Shomair
Corporate Officer/Principal en POINT Biopharma, Inc. (United States) .
Cargos activos de Ari Shomair
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
POINT Biopharma, Inc. (United States)
 POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Corporate Officer/Principal | - | - |
Historial de carrera de Ari Shomair
Antiguos cargos conocidos de Ari Shomair.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| POIT BIOP | Oficial de Recursos Humanos | - | 27/12/2023 |
| Public Communications Contact | - | - |
Estadísticas
Internacional
| Estados Unidos | 3 |
Operativa
| Human Resources Officer | 1 |
| Public Communications Contact | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 2 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| POIT BIOP | Health Technology |
| Empresas privadas | 1 |
|---|---|
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Commercial Services |
- Bolsa de valores
- Insiders
- Ari Shomair
- Experiencia
